[13] [15] There is a risk of oxalate nephropathy or kidney stone formation, particularly in patients with pre-existing renal impairment or those receiving prolonged high-dose therapy
Agonists of the GLP-1 receptor have been shown to increase levels of markers of bone formation (osteocalcin and procollagen type 1 N-terminal propeptide [P1NP]) and protect against loss of bone mineral content in obese women after weight loss while having no effect on plasma CTX-1 concentrations [59, 60]
In March, a group of researchers from Cedars-Sinai published similar findings, indicating that there is a 0.8% risk of aspiration pneumonia for those taking GLP-1 RAs, which can be reduced by 33% if patients stop taking the medication prior to the procedure
Sanni and our team at Eastside Bariatric & General Surgery in Snellville, Georgia, offers semaglutide injections to help you achieve your weight loss goals
doi: 10.1016/j.cmet.2019.07.013 157 DowsettGKCLamBYHTadrossJACiminoIRimmingtonDCollAPet al